![Sernova on X: "We are pleased to announce that our abstract has been selected for an oral podium presentation at the upcoming American Diabetes Association (ADA) 82nd Scientific Sessions, being held from Sernova on X: "We are pleased to announce that our abstract has been selected for an oral podium presentation at the upcoming American Diabetes Association (ADA) 82nd Scientific Sessions, being held from](https://pbs.twimg.com/media/FSV1ycoWUAImIyw.jpg)
Sernova on X: "We are pleased to announce that our abstract has been selected for an oral podium presentation at the upcoming American Diabetes Association (ADA) 82nd Scientific Sessions, being held from
![New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2018/09/Fig-2-for-EASD-ADA.jpg)
New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia
![American Diabetes Association - DiabetesPro on X: "Obesity Management as a Primary Treatment Goal for Type 2 Diabetes: It's Time for a Paradigm Shift — @psumithran1, @rvcohen, and @rizo_ivania presented during this American Diabetes Association - DiabetesPro on X: "Obesity Management as a Primary Treatment Goal for Type 2 Diabetes: It's Time for a Paradigm Shift — @psumithran1, @rvcohen, and @rizo_ivania presented during this](https://pbs.twimg.com/media/FUmhTymWAAAjXE4.jpg)
American Diabetes Association - DiabetesPro on X: "Obesity Management as a Primary Treatment Goal for Type 2 Diabetes: It's Time for a Paradigm Shift — @psumithran1, @rvcohen, and @rizo_ivania presented during this
![Extraordinary Leaders in Diabetes Research, Prevention, and Treatment to be Recognized at ADA's 82nd Scientific Sessions Extraordinary Leaders in Diabetes Research, Prevention, and Treatment to be Recognized at ADA's 82nd Scientific Sessions](https://mma.prnewswire.com/media/1765086/American_Diabetes_Association_SS2022_COMMS_AWARDS_Final.jpg)
Extraordinary Leaders in Diabetes Research, Prevention, and Treatment to be Recognized at ADA's 82nd Scientific Sessions
![Potential Gains in Life Expectancy (LE) Associated with Achieving Treatment Goals in People with Type 2 Diabetes (T2D) in the U.S. | Medfyle Potential Gains in Life Expectancy (LE) Associated with Achieving Treatment Goals in People with Type 2 Diabetes (T2D) in the U.S. | Medfyle](https://www.medfyle.com/articles/12-life-expectancy-in-t2d/download_file?filename=articles%2F469_cover.png)
Potential Gains in Life Expectancy (LE) Associated with Achieving Treatment Goals in People with Type 2 Diabetes (T2D) in the U.S. | Medfyle
![SDRI is proud to have a strong presence at upcoming 82nd ADA Scientific Sessions - Sansum Diabetes Research Institute SDRI is proud to have a strong presence at upcoming 82nd ADA Scientific Sessions - Sansum Diabetes Research Institute](https://sansum.org/wp-content/uploads/2022/03/ADA-2022.jpg)
SDRI is proud to have a strong presence at upcoming 82nd ADA Scientific Sessions - Sansum Diabetes Research Institute
![ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2022/09/Screenshot-2022-09-21-at-13.20.37.png)
ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia
![Medical Meeting News on X: "Coming up at #ADA2022: ➡️ Diabetes, Metabolic Health, and Clinical Care among People Who Are Lesbian, Gay, Bisexual, Transgender, Gender Diverse, Queer, or Questioning 🕙 4:30 p.m. Medical Meeting News on X: "Coming up at #ADA2022: ➡️ Diabetes, Metabolic Health, and Clinical Care among People Who Are Lesbian, Gay, Bisexual, Transgender, Gender Diverse, Queer, or Questioning 🕙 4:30 p.m.](https://pbs.twimg.com/media/FUg8K7JWYAEmDof.jpg)